Avara Pharmaceutical Services has closed on the transaction with Sandoz to acquire the largest sterile manufacturing facility for injectable medicines in Canada, as part of a continuing expansion of its global footprint.  “This acquisition represents an important addition to the Avara portfolio and further expands our sterile processing capability, which is in very high demand,” said Timothy C. Tyson, Avara’s chairman and chief executive officer. “It comes with a mar...